261201200033I (N01) | |||
---|---|---|---|
Title | IGF::OT::IGF TOPICAL EGCG (VEREGEN) IN CERVICAL DYSPLASIA, A FEASIBILITY CLINICAL TRIAL | ||
Institution | UNIVERSITY OF WISCONSIN-MADISON, , | ||
Principal Investigator | BAILEY, HOWARD | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $1,922,742 | Project Dates | null - null |
Fiscal Year | 2018 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) |
Bladder (33.0%) Breast (100.0%) Prostate (33.0%) |
||
Research Type | |||
Resources & Infrastructure Related to Biology Resources and Infrastructure Related to Treatment and the Prevention of Recurrence |
|||
Abstract | |||
No abstract available. |